Skip to content
STESteris

What Is STE Fair Value?

Steris (STE) fair value estimate using multiple valuation models, updated daily.

As of October 14, 2026, Steris (STE) has a composite fair value estimate of $142.51 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $217.77, suggesting the stock is overvalued by 34.6%.

Data as of October 14, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$142.51

vs. current price of $217.77(-34.6%)

Undervalued$142.51Overvalued
$217.77

How Is STE Fair Value Calculated?

Four independent models estimate what STE is worth. Each uses different inputs and assumptions. The composite blends them by weight.

STE Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$174.43

-19.9%

Overvalued

Inputs used

FCF: 798.9MGrowth: 9.8%Discount: 9%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$57.90

-73.4%

Overvalued

Inputs used

Dividend: $2.58/yrReq. Return: 10%Growth: 4.9%

STE Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$136.30

-37.4%

Overvalued

Inputs used

EPS: $11.17Book Value: $73.92

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$111.71

-48.7%

Overvalued

Inputs used

EPS: $11.17Growth: 9.8%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$174.43Overvalued

Current price $217.77 is 19.9% above this estimate

CheapFair ValueExpensive
9.8%
0.0%30.0%
9.1%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$877.4M$804.2M
Year 2$963.6M$809.6M
Year 3$1.06B$815.1M
Year 4$1.16B$820.5M
Year 5$1.28B$826.1M
Year 6$1.40B$831.6M
Year 7$1.54B$837.2M
Year 8$1.69B$842.8M
Year 9$1.86B$848.5M
Year 10$2.04B$854.2M
Terminal Value$31.71B$13.28B

What Are STE's Key Financial Metrics?

Earnings & Growth

Current Price

$217.77

EPS (TTM)

$8.18

Forward P/E

17.8

Profit Margin

13.3%

Cash & Balance Sheet

Free Cash Flow

798.9M

EBITDA

1.6B

Book Value

$73.92

Total Debt

2B

What Do Analysts Say About STE?

Low

$232.00

Average

$262.14

High

$280.00

Upside

+20.4%

Current $217.77Avg Target $262.14Buy7 analysts

STE Fair Value FAQ

What is the fair value of STE?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), STE's estimated fair value is $142.51. The stock is currently trading at $217.77, which makes it overvalued by our analysis.

How is STE's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is STE overvalued or undervalued?

Based on our analysis, STE is overvalued. The current price of $217.77 is 34.6% above our estimated fair value of $142.51.

What do Wall Street analysts say about STE?

7 analysts cover Steris with a consensus rating of "Buy." The average price target is $262.14, ranging from $232.00 to $280.00. This implies 20.4% upside from the current price.